Third Harmonic Bio Inc.
(THRD)
undefined
undefined%
At close: undefined
11.26
0.18%
After-hours Dec 13, 2024, 04:00 PM EST
Company Description
Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases.
It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by mast cell activation that results in red, itchy, painful welts, or hives, as well as for airway and gastrointestinal tract indications.
The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019.
Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts.
Third Harmonic Bio Inc.
| Country | United States |
| IPO Date | Sep 14, 2022 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 51 |
| CEO | Natalie C. Holles |
Contact Details
Address: 300 Technology Square Cambridge, Massachusetts United States | |
| Website | https://www.thirdharmonicbio.com |
Stock Details
| Ticker Symbol | THRD |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001923840 |
| CUSIP Number | 88427A107 |
| ISIN Number | US88427A1079 |
| Employer ID | 83-4553503 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Natalie C. Holles | Chief Executive Officer & Director |
| Jennifer Dittman | Chief Operating Officer |
| Christopher Murphy | Chief Financial & Business Officer |
| Dennis Dean Ph.D. | Chief Non-Clinical Development Officer |
| Dr. Christopher J. Dinsmore Ph.D. | Chief Scientific Officer |
| Dr. Edward R. Conner M.D. | Chief Medical Officer |
| Julie Person | Chief Administrative Officer |
| Ommer Chohan | Treasurer & Secretary |
| Steven P. Sweeney | Senior Vice President of Development Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Nov 12, 2024 | SC 13D/A | [Amend] Filing |
| Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 12, 2024 | 4 | Filing |
| Nov 07, 2024 | 8-K | Current Report |
| Nov 07, 2024 | 10-Q | Quarterly Report |
| Nov 05, 2024 | SC 13D/A | [Amend] Filing |
| Nov 05, 2024 | 4 | Filing |
| Oct 31, 2024 | 4 | Filing |